Figure S1 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Sara Bobisse
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
108Publications signalées
4983Citations signalées
0Affiliations récentes
Les domaines associés
CAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies ResearchRenal and related cancers
Les publications récentes
Figure S2 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S7 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Data from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S5 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S10 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S4 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Supplementary Table S2 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S6 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Supplementary Table S1 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S3 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S8 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.